Tamoxifen and estrogen attenuate enhanced vascular reactivity induced by estrogen deficiency in rat carotid arteries

Biochemical Pharmacology

Volumn 73, Issue 9, 2007, Pages 1330-1339

  Tsang, Suk Ying ^a   Yao, Xiaoqiang ^a   Chan, Hoi Yun ^a   Chan, Franky Leung ^a   Leung, Cecilia Sze Lee ^a   Yung, Lai Ming ^a   Au, Chak Leung ^a   Chen, Zhen Yu ^a   Laher, Ismail ^b   Huang, Yu ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chronic estrogen; Chronic tamoxifen; Common carotid arteries; Endothelium derived hyperpolarizing factor; Vascular reactivity

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 18ALPHA GLYCYRRHETINIC ACID; APAMIN; CHARYBDOTOXIN; ESTRADIOL; ESTROGEN; IBERIOTOXIN; N(G) NITROARGININE; OUABAIN; PHENYLEPHRINE; POTASSIUM ION; TAMOXIFEN; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL REACTIVITY; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG IMPLANTATION; ESTRADIOL BLOOD LEVEL; ESTROGEN DEFICIENCY; FEMALE; ISCHEMIC HEART DISEASE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR ENDOTHELIUM;

EID: 33947406857     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2006.12.022     Document Type: Article

References (39)

1. Barrett-Connor E., and Bush T.L. Estrogen and coronary heart disease in women. J Am Med Assoc 265 (1991) 1861-1867
2. Virdis A., Ghiadoni L., Pinto S., Lombardo M., Petraglia F., Gennazzani A., et al. Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women. Circulation 101 (2000) 2258-2263
3. Cid M.C., Schnaper H.W., and Kleinman H.K. Estrogens and the vascular endothelium. Ann NY Acad Sci 966 (2002) 143-157
4. Weiner C.P., Lizasoain I., Baylis S.A., Knowles R.G., Charles I.G., and Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91 (1994) 5212-5216
5. Rahimian R., Dube G.P., Toma W., Dos Santos N., McManus B.M., and van Breemen C. Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression. Eur J Pharmacol 434 (2002) 141-149
6. Rahimian R., Laher I., Dube G., and van Breemen C. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther 283 (1997) 116-122
7. Sakuma I., Liu M.Y., Sato A., Hayashi T., Iguchi A., Kitabatake A., et al. Endothelium-dependent hyperpolarization and relaxation in mesenteric arteries of middle-aged rats: influence of oestrogen. Br J Pharmacol 135 (2002) 48-54
8. Huang A., Sun D., Carroll M.A., Jiang H., Smith C.J., Connetta J.A., et al. EDHF mediates flow-induced dilation in skeletal muscle arterioles of female eNOS-KO mice. Am J Physiol Heart Circ Physiol 280 (2001) H2462-H2469
9. Gilligan D.M., Badar D.M., Panza J.A., Quyyumi A.A., and Cannon III R.O. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am J Cardiol 75 (1995) 264-268
10. Gisclard V., Miller V.M., and Vanhoutte P.M. Effect of 17 β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244 (1988) 19-22
11. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. J Am Med Assoc 288 (2000) 321-333
12. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. J Am Med Assoc 291 (2004) 1701-1712
13. McDonald C.C., and Stewart H.J. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. BMJ 303 (1991) 435-437
14. Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet 339 (1992) 71-85
15. Clarke S.C., Schofield P.M., Grace A.A., Metcalfe J.C., and Kirschenlohr H.L. Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis. Circulation 103 (2001) 1497-1502
16. Figtree G.A., Webb C.M., and Collins P. Tamoxifen acutely relaxes coronary arteries by an endothelium-, nitric oxide-, and estrogen receptor-dependent mechanism. J Pharmacol Exp Ther 295 (2000) 519-523
17. Hutchison S.J., Chou T.M., Chatterjee K., and Sudhir K. Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro. J Cardiovasc Pharmacol 38 (2001) 657-665
18. Song J., Standley P.R., Zhang F., Joshi D., Gappy S., Sowers J.R., et al. Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats. J Pharmacol Exp Ther 277 (1996) 1444-1453
19. Thorin E., Pham-Dang M., Clement R., Mercier I., and Calderone A. Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen. Br J Pharmacol 140 (2003) 1187-1192
20. Tsang S.Y., Yao X., Chan F.L., Wong C.M., Chen Z.Y., Laher I., et al. Estrogen and tamoxifen modulate cerebrovascular tone in ovariectomized female rats. Hypertension 44 (2004) 78-82
21. Simon T., Boutouyrie P., Simon J.M., Laloux B., Tournigand C., Tropeano A.I., et al. Influence of tamoxifen on carotid intima-media thickness in postmenopausal women. Circulation 106 (2002) 2925-2929
22. Skarsgard P., Breemen C.V., and Laher I. Estrogen regulates myogenic tone in pressurized cerebral arteries by enhanced basal release of nitric oxide. Am J Physiol Heart Circ Physiol 273 (1997) 2248-2256
23. Patisaul H.B., Luskin J.R., and Wilson M.E. A soy supplement and tamoxifen inhibit sexual behavior in female rats. Horm Behav 45 (2004) 270-277
24. Tohei A., Imai A., Watanabe G., and Kazugoshi T. Influence of thiouracil-induced hypothyroidism on adrenal and gonadal functions in adult female rats. J Vet Med Sci 60 (1998) 439-446
25. Walker Q.D., Francis R., Cabassa J., and Kuhn C.M. Effect of ovarian hormones and estrous cycle on stimulation of the hypothalamo-pituitary-adrenal axis by cocaine. J Pharmacol Exp Ther 297 (2001) 291-298
26. Barber D.A., and Miller V.M. Gender differences in endothelium-dependent relaxations do not involve NO in porcine coronary arteries. Am J Physiol 273 (1997) H2325-H2332
27. Vedernikov Y.P., Liao Q.P., Jain V., Saade G.R., Chwalisz K., and Garfield R.E. Effect of chronic treatment with 17β-estradiol and progesterone on endothelium-dependent and endothelium-independent relaxation in isolated aortic rings from ovariectomized rats. Am J Obstet Gynecol 176 (1997) 603-608
28. Altavilla D., Saitta A., Galeano M., Squadrito G., Marino D., Minutoli L., et al. The phytoestrogen alpha-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats. Lab Invest 81 (2001) 125-132
29. Wassmann S., Baumer A.T., Strehlow K., van Eickels M., Grohe C., Ahlbory K., et al. Endothelial dysfunction and oxidative stress during estrogen deficiency in spontaneously hypertensive rats. Circulation 103 (2001) 435-441
30. Golding E.M., and Kepler T.E. Role of estrogen in modulating EDHF-mediated dilations in the female rat middle cerebral artery. Am J Physiol Heart Circ Physiol 280 (2001) H2417-H2423
31. Chataigneau T., Zerr M., Chataigneau M., Hudlett F., Hirn C., Pernot F., et al. Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause 11 (2004) 255-263
32. Liu M.Y., Hattori Y., Fukao M., Sato A., Sakuma I., and Kanno M. Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term deficiency of oestrogen and during oestrus cycle. Br J Pharmacol 132 (2001) 1035-1046
33. Nawate S., Fukao M., Sakuma I., Soma T., Nagai K., Takikawa O., et al. Reciprocal changes in endothelium-derived hyperpolarizing factor- and nitric oxide-system in the mesenteric artery of adult female rats following ovariectomy. Br J Pharmacol 144 (2005) 178-189
34. Garland C.J., Plane F., Kemp B.K., and Cocks T.M. Endothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci 16 (1995) 23-30
35. Langton P.D., Nelson M.T., Huang Y., and Standen N.B. Block of calcium-activated potassium channels in mammalian arterial myocytes by tetraethylammonium ions. Am J Physiol 260 (1991) H927-H934
36. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396 (1998) 269-272
37. Edwards G., Feletou M., Gardener M.J., Thollon C., Vanhoutte P.M., and Weston A.H. Role of gap junctions in the responses to EDHF in rat and guinea-pig small arteries. Br J Pharmacol 128 (1999) 1788-1794
38. Chaytor A.T., Marsh W.L., Hutcheson I.R., and Griffith T.M. Comparison of glycyrrhetinic acid isoforms and carbenoxolone as inhibitors of EDHF-type relaxations mediated via gap junctions. Endothelium 7 (2000) 265-278
39. Xu H.L., Santizo R.A., Baughman V.L., and Pelligrino D.A. ADP-induced pial arteriolar dilation in ovariectomized rats involves gap junctional communication. Am J Physiol Heart Circ Physiol 283 (2002) H1082-H1091